Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Mesa Laboratories, Inc. - Common Stock (NQ:MLAB)

67.89 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Mesa Laboratories, Inc. - Common Stock

< Previous 1 2 Next >
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Mesa Laboratories Inc (NASDAQ:MLAB) Reports Mixed Q1 Fiscal 2026 Results: EPS Soars While Revenue Misses Estimates
Mesa Labs (MLAB) reported Q1 fiscal 2026 earnings with revenue missing estimates at $59.54M but EPS soaring to $2.32, beating forecasts. Stock surged 36.4% pre-market. 
Via Chartmill
Earnings Scheduled For August 5, 2025
 
Via Benzinga
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply Chain
Uncertainty has cast a pall over medical stocks, which are taking a "wait-and-see" approach to Trump's tariffs. 
Via Investor's Business Daily
Topics Government
MLAB Stock Earnings: Mesa Laboratories Beats EPS, Beats Revenue for Q4 2024
MLAB stock results show that Mesa Laboratories beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
Earnings Preview: Mesa Laboratories
 
Via Benzinga
Evercore ISI Group Upgrades Mesa Laboratories: Here's What You Need To Know
 
Via Benzinga
Earnings Scheduled For November 6, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. 
Via Benzinga
Recap: Mesa Laboratories Q4 Earnings
 
Via Benzinga
US Stocks Rise Despite China's Trade Fears, Palantir Defies Gravity, Gold Rallies Further: What's Driving Markets Tuesday?
U.S. stocks advanced midday Tuesday, demonstrating resilience despite escalating geopolitical tensions and trade uncertainties between the world’s two largest economies. 
Via Benzinga
Recap: Mesa Laboratories Q3 Earnings
 
Via Benzinga
Mesa Laboratories's Earnings Outlook
 
Via Benzinga
Mesa Laboratories's Return on Invested Capital Insights
 
Via Benzinga
Earnings Scheduled For February 4, 2025
 
Via Benzinga
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
 
Via Benzinga
Cogent Communications, Trimble And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher by over 100 points on Thursday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Earnings Outlook For Mesa Laboratories
 
Via Benzinga
Mesa Laboratories's Return On Capital Employed Insights
 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  Thursday saw 177 companies set new 52-week lows. 
Via Benzinga
Earnings Scheduled For February 5, 2024
Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is estimated to report quarterly earnings at $0.26 per share on revenue of $43.92 million. 
Via Benzinga
Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday
U.S. stocks closed higher on Tuesday, with the Dow Jones gaining around 400 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Earnings Scheduled For February 6, 2023
Companies Reporting Before The Bell • Cummins (NYSE:CMI) is projected to report quarterly earnings at $4.56 per share on revenue of $7.21 billion. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga
Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday
Gainers Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on... 
Via Benzinga
Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 99.1% to $4.42 after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel... 
Via Benzinga
Why Mesa Laboratories (MLAB) Stock Is Getting Hammered Today
Mesa Laboratories Inc (NASDAQ: MLAB) shares are trading lower by 12.89% to $160.40 Tuesday morning after the company announced its Clinical Genomics Division customer, Sema4, will exit the reproductive... 
Via Benzinga
Mesa Laboratories: Q2 Earnings Insights
Mesa Laboratories (NASDAQ:MLAB) reported its Q2 earnings results on Thursday, November 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings Mesa Laboratories posted... 
Via Benzinga
Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry. 
Via Benzinga
Why Lincoln National Shares Are Trading Lower By 31%? Here Are 72 Stocks Moving In Thursday's Session
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) gained 64% to $50.60. 
Via Benzinga
Mesa Laboratories's Return on Invested Capital Insights
According to Benzinga Pro data, during Q1, Mesa Laboratories (NASDAQ:MLAB) posted sales of $50.45 million. Earnings were up 19.39%, but Mesa Laboratories still reported an overall loss of $1.44... 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback